Clinical Trials Browser

Phase 3 × Neoplasm Metastasis × trilaciclib × Clear all

NCT04799249 2024-08-01

PRESERVE 2

Phase 3 Completed

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms